0.125% Atropine
Drugpatients used 0.125% atropine eyedrop per night before sleep for 7 days.
NCT Number: NCT03839888
In order we had designed a prospective clinical trial. Spherical equivalent refractive error (SER), axial length (AL), mean keratometric value (Mean-K), anterior chamber depth (ACD), and intraocular pressure (IOP) were measured at baseline and one week after topical use of 0.125% atropine. Postcycloplegic changes of refractive error and ocular parameters were evaluated, and their correlations were analyzed with multiple linear regression models.
Looking for future studies?
Notify Me3 year–18 year
All sexes
Interventional
Not applicable
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
patients used 0.125% atropine eyedrop per night before sleep for 7 days.
Time frame: change from SER at 7 days
Spherical equivalent refractive error
Time frame: change from AL at 7 days
Axial length
Time frame: change from ACD at 7 days
anterior chamber depth
Time frame: change from IOP at 7 days
intraocular pressure
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03334253
Eye Diseases, Myopia
Birmingham, Alabama, United States
View Trial DetailsNCT03918915
Eye Diseases, Myopia
Irwindale, California, United States
View Trial DetailsNCT07087665
Eye Diseases, Myopia
Saint Louis Park, Minnesota, United States
View Trial DetailsNCT06775509
Astigmatism, Eye Diseases
Tarragona, Spain
View Trial Details